Navigation Links
Par Pharmaceutical Companies Announces Settlement in Principle Regarding Certain Drug Pricing Lawsuits
Date:4/27/2011

WOODCLIFF LAKE, N.J., April 27, 2011 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today it reached a settlement in principle to resolve claims brought by the pharmacy Ven-A-Care of the Florida Keys, Inc. on behalf of the United States, Texas, and Florida under state and federal law, as well as claims brought by the Attorneys Generals of Alaska, South Carolina, and Kentucky under state law for $154 million (pre-tax).

Together with many other pharmaceutical manufacturers, Par is named as a defendant in numerous civil lawsuits that relate to drug price reporting by such companies. The cases, which are pending in federal and state courts, generally allege that the prices reported by pharmaceutical manufacturers caused government entities to pay inflated reimbursements for drugs under Medicaid or other programs. Par denies the allegations.

Upon execution of definitive settlement documents and certain government and court approvals, the settlement will resolve lawsuits relating to federal contributions to state Medicaid programs in 49 states (excluding Illinois), and claims of Texas, Florida, Alaska, South Carolina and Kentucky relating to their Medicaid programs. The settlement will eliminate the majority of the alleged damages asserted against Par in the various drug pricing litigations and removes all trials that had been scheduled to date.

About Par

Par Pharmaceutical Companies, Inc. is a US-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.

Safe Harbor Statement

Certain
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Diseases largely eradicated in the United States ... declared eliminated in 2000, yet the CDC reports 593 ... incidence in 20 years. In July, California,s ... problem of "epidemic proportions." Across ... preventable diseases—in part because some parents (more than 10 ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Multiple Sclerosis Drugs Market 2014-2018" report ... a chronic, inflammatory medical condition that results in demyelination, ... because of an abnormal response by the immune system, ... It is a potentially debilitating disease in which the ...
(Date:8/29/2014)... Calif. , Aug. 29, 2014  Pacific Medical ... its new website design . The main website, ... that showcases the company,s new services and content relevant ... implementing a new streamlined design, viewers can now better ... for health care practices and create a more visible ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3PMDS Announces New Website 2
... , NEW YORK, Nov. ... report is available in its catalogue: , United ... , http://www.reportlinker.com/p0158733/United-States-Dental-Devices-Market-Analysis-and-Forecasts-to-2015.html , United States Dental ... Summary , This report is an essential source ...
... , WALTHAM, Mass., Nov. 25 According ... market intelligence, the nearly $3 billion US market for trauma fixation ... years despite the recent economic slowdown. MRG,s US Markets for ... will remain highly dynamic over the next five years, with competitors ...
Cached Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3
(Date:8/31/2014)... 2014 Connexion Point, a leader in contact ... Magazine’s 2014 Fast 50, a ranking of the state’s fastest ... honored be in the top ten in the Utah Business ... a privately held company in one of the fastest growing ... list is an important achievement.” , Connexion Point has also ...
(Date:8/31/2014)... Evergreen, CO (PRWEB) August 31, 2014 ... has released award winning, “Simplicity & Sophistication: Short ... written and narrated by Dr. James W. Jackson ... & Sophistication,” Dr. Jackson compresses his vast ... nearly four decades into over 150 countries on behalf ...
(Date:8/31/2014)... With the NCAA set to undergo significant change, ... with Yale University Associate Athletic Director Steve Conn to ... ensuring student-athlete experience that is consistent with the University’s ... of key factors that contribute to a positive sports ... creating this culture seems simple at first. “The athletes ...
(Date:8/31/2014)... Sunday 31 August 2014: Wine only protects against cardiovascular ... from the In Vino Veritas (IVV) study presented at ... Czech Republic. , Professor Taborsky said: "This is the ... white wine on markers of atherosclerosis (1) in people ... that moderate wine drinking was only protective in people ...
(Date:8/30/2014)... Saturday 30 August 2014: A new method to ... defibrillators (AEDs) was presented at ESC Congress today by ... method, Paris needs 350 AEDs located in public places ... (OHCA). , Dr Dahan said: "Out of hospital cardiac ... annual incidence ranging between 50 and 100 per 100 ...
Breaking Medicine News(10 mins):Health News:Connexion Point Named Utah Business Magazine’s Top 10 Fastest Growing Companies in Utah 2Health News:Brook Forest Voices Announces End of Summer Release! Dr. James Jackson’s, “Simplicity & Sophistication” Audiobook 2Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 2Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 3Health News:Wine only protects against CVD in people who exercise 2Health News:New method predicts optimal number and location of AEDs 2
... Physicians could do a much better job of communicating critical ... their patients, a new UCLA study has found//. ,The ... the Archives of Internal Medicine, found that in too many ... of a medication, potential adverse side effects or even the ...
... treatment in multiple sites of care may now be able ... to a study that will appear in the Sept. 25 ... was led by Eric Coleman, MD, an associate professor at ... School of Medicine, and conducted through its Division of Health ...
... statin medications reduces death and cardiovascular events for ... acute heart events//, according to an analysis. ... clearly been shown to benefit patients with cardiovascular ... However, it is less clear whether these drugs ...
... to vanquish the big time killer AIDS/ HIV infection ... spearheaded// by Dr Benigno Rodriguez M.D and his extensive ... have presented their latest findings in the current issue ... have been questioned by the latest findings, which contest ...
... announced that they have finished the preliminary work in understanding ... far from complete, but it is designed to act as ... was led by researchers at the National Institute of Aging ... The data were derived from blood samples of 267 people ...
... drugs after researchers warned that some of them ... ,The new data, culled from 140,000 patients, ... attack risk. ,The European Medicines Agency ... ibuprofen, indomethacin, ketoprofen, ketorolac, meloxicam, nabumetone, naproxen, nimesulide ...
Cached Medicine News:Health News:Physician Communication Spotty When Prescribing Medications 2Health News:'Health Care Coaches' Can Help Reduce Patient Bills, Rehospitalization 2Health News:Early Statin Therapy for Patients Reduces Death, Cardiovascular Events 2Health News:Parkinson's Disease And Genetics 2
Straight shafts with extra fine pointed tips and 6mm tying platform. Smooth handle with dull finish/...
... utilizes a small-cone design and Placido ... complete, shadow-free representation of the corneal ... that includes the topographer, PC, software, ... enables quick and easy access to ...
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
... lighted dials to make it easier and ... darkened setting of the exam room. Put ... lights off throughout the entire process. The ... and cylinder axis scales that are easier ...
Medicine Products: